Back

BB-meta-HF - Beta-blockers are effective in high-risk heart failure patients with reduced ejection fraction and moderately-severe renal dysfunction

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hot Line Session 4 Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2019

ESC TV

About the speaker

Photo
Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
Discussant review - BB-meta-HF
Professor T. McDonagh (London, GB)
Slides Video
Presentation thumbnail
Questions from the audience and discussion
Video
Presentation thumbnail
SYNTAXES - Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study
Mr D. Thuijs (Rotterdam, NL)
Slides Video
Presentation thumbnail
Discussant review - SYNTAXES
Doctor G. Stone (New York City, US)
Slides Video
Presentation thumbnail
Questions from the audience and discussion
Video

Access the full session

Session thumbnail
Hot Line Session 4

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources